# RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

> **NCT07553065** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Vensica Therapeutics Ltd.** · enrollment: 210 (estimated)

## Conditions studied

- Overactive Bladder (OAB)

## Interventions

- **COMBINATION_PRODUCT:** NT 201 200U and Vibe System
- **COMBINATION_PRODUCT:** NT 201 300U and Vibe System
- **COMBINATION_PRODUCT:** Placebo and sham

## Key facts

- **NCT ID:** NCT07553065
- **Lead sponsor:** Vensica Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553065, "RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07553065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*